多发性骨髓瘤患者的低酸血症
Ivan Cancarevic1, Usman Ilyas1, Mahmoud Nassar2
1Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA.
低酸血症是多发性骨髓瘤患者常见的电解质问题,有多种原因,包括瘤效应和药物. 了解这些触发因素有助于早期发现和管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 低血是经常发生的电解质障碍,特别是在癌症患者中,通常与不良结果有关.
- 平衡涉及甲状腺上腺激素 (PTH),纤维细胞生长因子-23 (FGF-23) 和维生素D之间的复杂相互作用.
- 低酸血的临床表现是非特异性的,导致诊断延迟.
研究的目的:
- 审查多发性骨髓瘤患者中低酸血的原因和后果.
- 阐明这种特定患者群体中低酸血症背后的机制.
主要方法:
- 进行了叙事文学评论.
- 通过在PubMed数据库中搜索多发性骨髓瘤中低血症,确定了相关的文章.
主要成果:
- 多发性骨髓瘤患者表现出各种原因的低酸血症,包括瘤诱导的骨质疏松症和Fanconi综合征.
- 像双酸盐和新型骨髓瘤疗法这样的药物可以通过直接作用或通过改变和PTH水平来导致低酸血症.
- 轻链和某些药物可以诱导Fanconi综合征,导致损耗.
结论:
- 识别多发性骨髓瘤中低酸血的特定触发因素对于有针对性的查至关重要.
- 了解各种机制有助于临床医生积极主动地管理和监测患者.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
What is the Skeletal System?
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Skeleton and Calcium Homeostasis
